Fast and reliable detection of patients with severe and heterogeneous illnesses is a major
goal of precision medicine 1 , 2 . Patients with leukaemia can be identified using machine …

Background While the leading symptoms during coronavirus disease 2019 (COVID-19) are
acute and the majority of patients fully recover, a significant fraction of patients now …

CD4 + T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these
are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, …

Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-19
pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody …

SARS-CoV-2 neutralizing antibodies play a critical role in COVID-19 prevention and
treatment but are challenged by viral evolution and the emergence of novel escape variants. …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has spread rapidly worldwide. Given scarce resources, …

A fraction of COVID-19 convalescent individuals mount a potent antibody response to SARS-CoV-2
with cross-reactivity to SARS-CoV-1. To uncover their humoral response in detail, we …

Background COVID-19 has so far affected more than 250 million individuals worldwide, causing
more than 5 million deaths. Several risk factors for severe disease have been identified, …

Background Symptoms lasting longer than 12 weeks after severe acute respiratory
syndrome coronavirus type 2 (SARS-CoV-2) infection are called post-coronavirus disease (COVID) …

The coronavirus disease (COVID-19) pandemic has caused tremendous pressure on
hospital infrastructures such as emergency rooms (ER) and outpatient departments. To avoid …